Village Farms International, Inc. VFF
Our mission is to apply decades of innovation in intensive agriculture to build a sustainable path forward for the global cannabis industry. To achieve this, we are building upon over three decades of leadership in Controlled Environment Agriculture ("CEA"), asset development and management, marketing of plant-based consumer packaged goods to deliver a full suite of recreational and medicinal products and brands to regulated cannabis markets across the world.
We have leveraged our expertise as a pioneer in CEA to contribute meaningfully to the development of the global legal cannabis industry. Pure Sunfarms Corp. ("Pure Sunfarms" or "PSF") and Rose LifeScience Inc. ("Rose LifeScience" or "Rose") comprise our Canadian cannabis businesses. Pure Sunfarms is one of the largest and most respected cannabis growers in the world and the leading flower brand in Canada. Rose is a leading vertically integrated, branded cannabis producer, supplier and commercialization expert in the Province of Quebec.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $215.9M | $195.9M | $163.1M | $293.6M | $268.0M | $170.1M | $144.6M | $150.0M | $158.4M | — |
| Cost of revenue | $128.3M | $150.1M | $115.2M | $266.1M | $222.8M | $159.1M | $151.9M | $140.7M | $144.4M | — |
| Gross profit | $87.7M | $45.8M | $48.0M | $27.5M | $45.2M | $11.0M | -$7.3M | $9.3M | $14.0M | — |
| SG&A | $60.3M | $61.7M | $56.7M | $72.3M | $53.9M | $19.1M | $16.8M | $14.1M | $14.9M | — |
| Operating income | — | — | — | — | — | — | — | -$6.7M | -$1.2M | — |
| Interest expense | $2.7M | $3.4M | $4.5M | $3.2M | $2.8M | $2.1M | $2.6M | $2.8M | $2.7M | — |
| Pre-tax income | $31.4M | -$29.6M | -$25.6M | -$96.7M | -$12.7M | $8.8M | -$3.5M | -$9.8M | -$5.5M | — |
| Income tax | $10.4M | $1.7M | $7.5M | $4.7M | $3.5M | $2.8M | $5.9M | $2.3M | $763.0K | — |
| Net income | $32.4M | -$33.9M | -$34.8M | -$101.1M | -$9.1M | $11.6M | $2.3M | -$7.5M | -$4.8M | — |
| EPS, basic | 0.29 | -0.32 | -0.32 | -1.13 | -0.11 | 0.20 | 0.05 | -0.17 | -0.12 | — |
| EPS, diluted | 0.27 | -0.32 | -0.32 | -1.13 | -0.11 | 0.19 | 0.05 | -0.17 | -0.12 | — |
| Shares, diluted (wtd. avg.) | 118.5M | 111.4M | 108.7M | 89.1M | 82.2M | 61.5M | 51.2M | 44.4M | 39.1M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $81.2M | $24.6M | $35.3M | $21.7M | $58.7M | $25.7M | $12.0M | $11.9M | $7.1M | $5.4M |
| Receivables | $23.2M | $22.2M | $30.6M | $27.6M | $34.4M | $23.2M | $9.0M | $11.3M | — | — |
| Inventory | $41.5M | $41.3M | $78.5M | $70.6M | $68.7M | $46.6M | $15.9M | $25.0M | — | — |
| Total current assets | $154.4M | $116.0M | $151.8M | $133.0M | $175.0M | $101.8M | $54.6M | $60.3M | — | — |
| Property, plant and equipment | $185.7M | $175.2M | $205.6M | $207.7M | $215.7M | $187.0M | $63.2M | $72.2M | — | — |
| Goodwill | $44.4M | $42.3M | $55.9M | $66.2M | $117.5M | $24.0M | — | — | — | — |
| Other intangibles | $23.6M | $25.1M | $32.3M | $37.2M | $26.4M | $17.3M | — | — | — | — |
| Total assets | $423.1M | $389.3M | $464.0M | $465.3M | $566.9M | $354.0M | $183.4M | $141.4M | $142.3M | — |
| Accounts payable | $15.7M | $11.3M | $21.8M | $24.9M | $22.6M | $15.1M | $12.7M | $14.6M | — | — |
| Short-term debt | $4.9M | $8.1M | $9.1M | $9.6M | $11.4M | $10.2M | $3.4M | $3.4M | — | — |
| Total current liabilities | $58.6M | $62.2M | $72.2M | $72.2M | $64.3M | $72.3M | $22.0M | $23.6M | — | — |
| Long-term debt | $28.8M | $32.4M | $38.9M | $43.8M | $50.4M | $53.9M | $29.0M | $32.3M | — | — |
| Total liabilities | $113.0M | $125.3M | $148.0M | $145.3M | $142.1M | $148.7M | $56.9M | $57.0M | — | — |
| Retained earnings | -$112.6M | -$145.0M | -$109.2M | -$74.4M | $26.8M | $35.9M | $24.2M | $21.9M | — | — |
| Total equity | $299.9M | $254.0M | $300.3M | $303.8M | $408.4M | $205.3M | $126.5M | $84.4M | $66.9M | $60.0M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $58.1M | $13.7M | $7.6M | -$19.9M | -$39.6M | $5.7M | -$14.4M | -$4.7M | $669.0K | — |
| Depreciation and amortisation | $16.4M | $16.7M | $14.1M | $13.1M | $12.7M | $6.8M | $7.4M | $7.0M | $7.7M | — |
| Stock-based compensation | $1.7M | $3.7M | $3.1M | $4.0M | $7.5M | $6.1M | $4.7M | $1.5M | $1.5M | — |
| Capital expenditure | $18.2M | $7.2M | $3.6M | $14.3M | $21.7M | $3.4M | $2.3M | $3.1M | $1.7M | — |
| Investing cash flow | -$18.6M | -$7.3M | -$3.3M | -$20.9M | -$63.5M | -$51.2M | -$16.8M | -$13.5M | -$1.7M | — |
| Financing cash flow | -$6.4M | -$9.5M | $14.1M | $4.5M | $135.9M | $58.6M | $31.4M | $23.0M | $2.8M | — |
| Buybacks | $3.0M | — | — | — | $5.0M | — | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-192149.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $158.4M | $150.0M | $144.6M | $170.1M | $268.0M | $293.6M | $163.1M | $195.9M | $215.9M |
| Gross profit | — | $14.0M | $9.3M | -$7.3M | $11.0M | $45.2M | $27.5M | $48.0M | $45.8M | $87.7M |
| Net income | — | -$4.8M | -$7.5M | $2.3M | $11.6M | -$9.1M | -$101.1M | -$34.8M | -$33.9M | $32.4M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Regulation FD disclosure Item 7.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Regulation FD disclosure Item 7.01
- Results announced Item 2.02
- Regulation FD disclosure Item 7.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Regulation FD disclosure Item 7.01
- Material agreement signed Item 1.01
- Regulation FD disclosure Item 7.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 0100
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DMC | DEL MONTE CORP | $1.39B | 15.7x | 1.0% |
| DOLE | Dole plc | $1.27B | 25.4x | 8.2% |
| ALCO | ALICO, INC. | $275.7M | — | -5.5% |
| LMNR | Limoneira CO | $195.3M | — | -17.3% |
| LOCL | Local Bounti Corporation/DE | $22.2M | — | 26.8% |
| TULP | BLOOMIA HOLDINGS, INC. | $11.5M | — | — |
| EDBL | Edible Garden AG Inc | $1.6M | — | — |
| AGRO | Adecoagro S.A. | — | — | — |